Portfolio company
ALIGNED BIO
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops nanowire-based biosensor platforms for single-molecule detection within the medical diagnostics and DNA sequencing markets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Seed, 2024
This company develops a single-molecule DNA sequencing platform for clinical diagnostics, agriculture, and biosecurity sectors.
Palamedrix
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Alveo
This company develops portable molecular diagnostic platforms for rapid pathogen detection in agriculture, food safety, environmental monitoring, and human healthcare sectors.
Geneseque
This company develops a single-molecule DNA sequencing technology for the life sciences sector and research partners.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
Motley Bio
This company develops multi-omic sequencing technology for disease detection and drug discovery services for biotechnology and pharmaceutical firms.